0TDG.L
Sociedad Química y Minera de Chile S.A.
LSEUSDEQUITY
DELAYED
Last price
82.23
▲ 4.69 (6.05%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
79.64
Prev close
77.54
Day high
84.08
Day low
78.78
Volume
1.53K
Market cap
—
P/E (TTM)
0.18
52W range
38.52 – 85.18
Day trading desk
Gap from prior close
—
—
VWAP
82.36
-0.16% from price
Relative volume
0.47×
Quiet session
Session range
6.73%
78.78 – 84.08
Position in range
65%
Mid range
ATR (14D)
—
Daily true range
Prior day high
—
PDH
Prior day low
—
PDL
Bid / ask spread
—
Quote not published
Session volume
1.58K
Avg 3.40K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 0TDG.L open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
0
Total on file
Fundamentals
Market cap—
Enterprise value$26.82B
Revenue (TTM)$6.73B
Gross profit$2.84B
EBITDA$3.00B
Net income$1.39B
EPS (TTM)$4.51
Free cash flow$2.62B
Total cash$4.35B
Total debt$5.31B
Book value / share$22.10
Shares outstanding263.20M
Float104.33M
Short % of float—
Dividend yield—
Beta (5Y)1.00
Valuation & profitability ratios
Trailing P/E0.18
Forward P/E6.14
PEG ratio—
Price / sales—
Price / book3.72
EV / revenue3.99
EV / EBITDA8.93
Gross margin42.17%
Operating margin48.82%
Profit margin20.62%
Return on equity21.82%
Return on assets11.55%
Debt / equity61.25
Current ratio2.61
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $2.28B | +94.2% |
| Next quarter | — | — | $2.10B | +58.7% |
| Current year | — | — | $7.77B | +69.7% |
| Next year | — | — | $7.95B | +2.4% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders0.00%
Held by institutions33.57%
Institutions holding489
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
—
—
SMA 20
—
—
SMA 50
—
—
SMA 100
—
—
SMA 200
—
—
EMA 12
—
—
EMA 26
—
—
EMA 50
—
—
RSI (14)
—
—
MACD (12,26,9)
—
Hist —
ATR (14)
—
—
Realised vol 30D
—
Annualised
Bollinger upper
—
20, 2σ
Bollinger lower
—
20, 2σ
50 / 200 cross
—
—
Trend bias
—
—
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
—
—
Correlation to SPY
—
—
Realised vol 30D
—
Annualised
Market vol 1Y
—
SPY, annualised
Max drawdown 1Y
—
Peak to trough
Max drawdown 5Y
—
Peak to trough
ATR 14
—
Average true range
Beta (reported)
1.00
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 28, 26 | Scotiabank | MAINTAINED | Sector Outperform | Sector Outperform |
| Jul 15, 26 | Goldman Sachs | MAINTAINED | Neutral | Neutral |
| Jul 14, 26 | Deutsche Bank | MAINTAINED | Buy | Buy |
| Jun 2, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| May 28, 26 | Scotiabank | MAINTAINED | Sector Outperform | Sector Outperform |
| Mar 25, 26 | B of A Securities | MAINTAINED | Underperform | Underperform |
| Mar 4, 26 | Scotiabank | MAINTAINED | Sector Outperform | Sector Outperform |
| Jan 21, 26 | Deutsche Bank | MAINTAINED | Buy | Buy |
| Jan 20, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Jan 13, 26 | Deutsche Bank | UPGRADE | Hold | Buy |
| Jan 12, 26 | Scotiabank | MAINTAINED | Sector Outperform | Sector Outperform |
| Dec 17, 25 | JP Morgan | UPGRADE | Neutral | Overweight |
Headlines
Joe Milton III's best plays from 3-TD game vs. Cardinals Preseason Week 2
NFL Highlights · 11m ago
BioNTech (BNTX) Is Up 25.2% After First-in-Class Pumitamig Plus B7H3 ADC Lung Data – What's Changed
Simply Wall St. · 17m ago
Applied Industrial Technologies (AIT) Could Be 15% Undervalued After Earnings And 2027 Guidance
Simply Wall St. · 17m ago
Everpure (P) Lands Supply Agreement With A Second Top Five Hyperscaler
Simply Wall St. · 17m ago
Is Red Cat Holdings (RCAT) Quietly Recasting Its Identity From Drone Maker To Full Autonomy Platform?
Simply Wall St. · 17m ago
Darling Ingredients (DAR) Stock Looks Undervalued On Broader Checks Yet Fair On Earnings
Simply Wall St. · 17m ago
LifeMD (LFMD) Stock Sees Fair Value Cut After Analysts Lower Targets On Weaker Guidance
Simply Wall St. · 17m ago
Is Vivmark Residential (VMRK) Undervalued Following Its Index Exits And Financing Moves?
Simply Wall St. · 18m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.